MBX 1416 is an investigational long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist in development as a potential ...

MBX Biosciences (MBX) completed the last subject’s last visit in its Phase 1 single and multiple ascending dose trial of MBX 1416, the company’s long-acting glucagon-like peptide 1 receptor antagonist ...

Anxiety can stem from various causes: a stressful situation, a medical condition, an uncomfortable environment, trauma, a ...

DelveInsight’s “Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an ...

Reports of fluoroquinolone-induced hypoglycemia are abundant, but reports of hyperglycemia induced by fluoroquinolones are also available. [15–19] The primary theory of fluoroquinolone ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Deprescription and the prevention of hospitalization should be priorities, rather than aggressive management, a family ...

1 Faculty of Medicine, Bogomolets National Medical University (NMU), Kyiv, Ukraine 2 Faculty of Medicine, Alborz University of Medical Sciences (ABZUMS), Karaj, Iran Postprandial hypoglycemia (PPH) is ...

Financial writer recaps Baird's upgrade of Amylyx Pharmaceuticals (AMLX) to Outperform on positive outlook for avexitide and ...

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment ...

Hypoglycemia or low blood sugar level is quite common in diabetics. But it does not mean people without diabetes can't experience it. Prediabetics, people who eat carbohydrate-rich foods or those who ...